According to the research report titled, ‘Global Intragastric Balloon Market 2019-2028’, available with MarketStudyReport, global intragastric balloon market is anticipated to exhibit a CAGR of 12.33% during 2019-2028.
 

Increasing prevalence of obesity and short hospital stays and recovery time using intragastric balloon solutions are the major factors propelling the growth of global intragastric balloon market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552678/
 

For the unversed, intragastric ballooning refers to a medical procedure that does not require any sort of stiches or incisions. The process generally takes around 20 minutes and the patients are discharges in about two hours post the insertion.
 

In addition, rising health concerns associated with morbid lifestyle and surging R&D investment by various governments to reduce obesity rate are augmenting industry outlook.
 

On the contrary, poor reimbursement scenario, rigid product approval process, and short-term effect related to intragastric ballooning are likely to hamper the remuneration scope of this marketplace on the ensuing years.
 

By component type, the market sphere is split into single balloon, dual balloon, and triple balloon. On the basis of filling material, global intragastric balloon market is bifurcated into saline filled and gas filled.
 

In terms of industry verticals, the market sphere is fragmented into clinics, hospitals, and ambulatory surgical centers.
 

Speaking of the geographical landscape, North America, Middle East & Africa, Latin America, Asia Pacific, and Europe are considered to understand the dynamics of this business sphere. Asia Pacific market is projected to amass notable gains during 2019-2028 owing to  surging sedentary lifestyle and unhealthy diet consumption.
 

Furthermore, rising incidences of obesity has resulted in increased pervasiveness of disease like diabetes, hypertension, strokes, and heart ailments. This in turn has escalated the demand for weight loss procedures like intragastric balloon implantation in the region, which in turn is facilitating the business scenario in Asia-Pacific.
 

Key players defining the competitive hierarchy of  global intragastric balloon market are Spatz FGIA Inc., Helioscopie S.A., Silimed Inc. (Sientra Inc.), Medtronic  plc, Endalis, Districlass Medical S.A., Baronova Inc., Aspire Bariatrics Inc., ReShape Lifesciences Inc.,  Apollo Endosurgery Inc., Obalon Therapeutics Inc., Allergan Inc. (AbbVie, Inc), MedSil LLC,  and Allurion Technologies Inc.